SynBioBeta Speaker
Stacie Calad-Thomson
BD, Life Sciences
NVIDIA
May 2026, SynBioBeta
Speaker
Stacie, a former pharma and biotech leader, recently joined NVIDIA to further enable AI adoption across healthcare and the life sciences. She also serves as the vice chair of the Alliance for Artificial Intelligence in Healthcare (AAIH). In her 13+ years at GSK, she led R&D initiatives and co-founded the ATOM consortium. More recently, she held leadership roles at AI drug discovery startups Atomwise, where she was a VP of Partnerships, and BioSymetrics, where she was the Chief Strategy Officer. Stacie holds a B. S. in chemistry from the University of California, Berkeley and a Ph. D. in organic chemistry from UC Irvine.
All Categories
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Conference Pass
1,995
USD
Save $1,000
Regular Rate
$2,995
Access to all 120+ Sessions
Attendee Directory
Networking Reception
1:1 Partnering App
1:1 Meeting Space
Lunch & Refreshments
Post Event Video Access
Price increases in
Purchase Pass
Purchase Pass
Cyber Week Deal
Buy 1 Conference Pass, Get 1 Expo Pass Free
Previous Speakers Include
Join for the latest
SynBioBeta event updates.